F
Feiko O. ter Kuile
Researcher at Liverpool School of Tropical Medicine
Publications - 245
Citations - 14511
Feiko O. ter Kuile is an academic researcher from Liverpool School of Tropical Medicine. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 59, co-authored 218 publications receiving 12969 citations. Previous affiliations of Feiko O. ter Kuile include Malawi-Liverpool-Wellcome Trust Clinical Research Programme & University of Ouagadougou.
Papers
More filters
Journal ArticleDOI
A model of parity-dependent immunity to placental malaria
Patrick G T Walker,Jamie T. Griffin,Matthew Cairns,Stephen J. Rogerson,Anna Maria van Eijk,Anna Maria van Eijk,Feiko O. ter Kuile,Feiko O. ter Kuile,Azra C. Ghani +8 more
TL;DR: It is suggested that preventative strategies implementable before or early in pregnancy, such as insecticide-treated net usage in women of child-bearing age or any future vaccine, could substantially reduce the number of women who experience placental infection.
Journal ArticleDOI
Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries.
TL;DR: There is an urgent need to develop targeted pharmacovigilance systems to assess the safety of antimalarials in early pregnancy, according to Feiko ter Kuile and colleagues.
Journal ArticleDOI
Sulfadoxine-Pyrimethamine in Treatment of Malaria in Western Kenya: Increasing Resistance and Underdosing
Dianne J. Terlouw,Bernard L. Nahlen,Bernard L. Nahlen,Bernard L. Nahlen,Jeanne M. Courval,Simon Kariuki,Oren S. Rosenberg,Aggrey J. Oloo,Margarette S. Kolczak,William A. Hawley,William A. Hawley,Altaf A. Lal,Feiko O. ter Kuile,Feiko O. ter Kuile,Feiko O. ter Kuile +14 more
TL;DR: Treatment guidelines should ensure that adequate doses are given from the initial deployment of antimalarials onward, as results raise concern about the longevity of sulfadoxine-pyrimethamine in these settings.
Journal ArticleDOI
The household-level economics of using permethrin-treated bed nets to prevent malaria in children less than five years of age.
Martin I. Meltzer,Dianne J. Terlouw,Margarette S. Kolczak,Amos Odhacha,Feiko O. ter Kuile,John M. Vulule,Jane Alaii,Bernard L. Nahlen,William A. Hawley,Penelope A. Phillips-Howard +9 more
TL;DR: Both seasonal effects and number of children per household had larger impacts than ITNs on health care expenditures and time lost from household activities, and the widespread adoption of the ITNs will therefore probably require a subsidy.
Journal ArticleDOI
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
André Daher,André Daher,Ghait Aljayyoussi,Dhelio Batista Pereira,Marcus V. G. Lacerda,Márcia A. A. Alexandre,Cristiana T. Nascimento,Júlio Castro Alves,Laís Bastos da Fonseca,Diego Medeiros Dias da Silva,Douglas Pereira Pinto,Danielle Fonseca Rodrigues,Ana Carolina Rios Silvino,Taís Nóbrega de Sousa,Cristiana Ferreira Alves de Brito,Feiko O. ter Kuile,David G. Lalloo +16 more
TL;DR: Genotyping of P. vivax showed that activation of related (homologous) hypnozoites was the most frequent cause of recurrence, and the high proportion of the impaired CYP2D6 activity among patients with recurrent infections suggests that slow primaquine metabolism might influence related relapse rates in Brazil among patients receivingPrimaquine for radical cure, although confirmatory studies are needed.